HK1177419A1 - Interleukin-1 blocker for use in the treatment of age-related macular degeneration -1 - Google Patents

Interleukin-1 blocker for use in the treatment of age-related macular degeneration -1

Info

Publication number
HK1177419A1
HK1177419A1 HK13104366.3A HK13104366A HK1177419A1 HK 1177419 A1 HK1177419 A1 HK 1177419A1 HK 13104366 A HK13104366 A HK 13104366A HK 1177419 A1 HK1177419 A1 HK 1177419A1
Authority
HK
Hong Kong
Prior art keywords
blocker
interleukin
age
treatment
macular degeneration
Prior art date
Application number
HK13104366.3A
Other languages
English (en)
Chinese (zh)
Inventor
George C Chiou
Original Assignee
Texas A & M Univ Sys
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas A & M Univ Sys filed Critical Texas A & M Univ Sys
Publication of HK1177419A1 publication Critical patent/HK1177419A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK13104366.3A 2005-05-12 2013-04-10 Interleukin-1 blocker for use in the treatment of age-related macular degeneration -1 HK1177419A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68099805P 2005-05-12 2005-05-12
US77642606P 2006-02-24 2006-02-24
US11/416,773 US8088773B2 (en) 2005-05-12 2006-05-03 Therapeutic compositions and methods

Publications (1)

Publication Number Publication Date
HK1177419A1 true HK1177419A1 (en) 2013-08-23

Family

ID=37431545

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13104366.3A HK1177419A1 (en) 2005-05-12 2013-04-10 Interleukin-1 blocker for use in the treatment of age-related macular degeneration -1

Country Status (10)

Country Link
US (5) US8088773B2 (xx)
EP (3) EP2508183B1 (xx)
JP (2) JP5335419B2 (xx)
AU (1) AU2006247892B2 (xx)
CA (1) CA2608163C (xx)
DE (1) DE202006020318U1 (xx)
ES (1) ES2598277T3 (xx)
HK (1) HK1177419A1 (xx)
PL (1) PL2508182T3 (xx)
WO (1) WO2006124324A1 (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007120828A1 (en) * 2006-04-14 2007-10-25 Novartis Ag Use of il-i antibodies for treating ophthalmic disorders
US7736860B2 (en) * 2006-11-09 2010-06-15 Univeristy Of Massachusetts Methods of identifying compounds for the treatment of sterile inflammation
GB0625270D0 (en) * 2006-12-19 2007-01-31 Univ Leicester Angiogenesis
EP3292868A1 (en) * 2009-08-24 2018-03-14 Stealth Peptides International, Inc. Methods and compositions for preventing or treating opthalmic conditions
CN104768533A (zh) 2012-06-11 2015-07-08 马库克利尔公司 治疗性制剂和治疗方法
CA2884644A1 (en) * 2012-09-13 2014-03-20 Cba Pharma, Inc. Tetrandrine pharmaceutical formulations and method
WO2015012210A1 (ja) 2013-07-23 2015-01-29 エーザイ・アール・アンド・ディー・マネジメント株式会社 ヘテロ縮合環化合物
US9370503B1 (en) * 2015-02-26 2016-06-21 Chi Chou Liao Compounds for treating ocular diseases
TWI794361B (zh) 2017-12-11 2023-03-01 美商阿爾提羅生命科學公司 大麻二酚之新固體形式及其使用
CA3103436A1 (en) 2018-06-11 2019-12-19 The Regents Of The University Of California Demethylation to treat eye disease
CN110585196B (zh) * 2018-06-13 2022-11-04 郭涛 一种治疗及预防眼科疾病的药物及其应用
CN112007031A (zh) * 2019-05-30 2020-12-01 杏国新药股份有限公司 眼用制剂
CN114276251B (zh) * 2021-12-07 2022-12-16 武汉大学 一种合成硝基(杂)芳烃的方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4055645A (en) * 1976-02-13 1977-10-25 Merck & Co., Inc. Novel anti-hypertensive compositions
FI873428A (fi) * 1986-08-18 1988-02-19 Houston Biotechnology Oftalmologiska kompositioner foer behandling av nervdegenerationer.
US4865599A (en) * 1986-08-18 1989-09-12 Houston Biotechnology, Inc. Ophthalmic compositions for treating nerve degeneration
IT1201151B (it) 1987-01-14 1989-01-27 Indena Spa Complessi fosfolipidici con estratti da vitis vinifera,procedimento per la loro preparazione e composizioni che li cntengono
US5500230A (en) * 1987-01-23 1996-03-19 The General Hospital Corporation Method for treatment of glaucoma with nitrogen containing guanylate cyclase activators
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5194434A (en) * 1991-12-03 1993-03-16 Texas A&M University System Use of OB-101 to treat ocular inflammation
US5252607A (en) 1992-01-24 1993-10-12 Texas A&M University System Treatment of low pressure glaucoma and ischemic retinal degeneration
US5459133A (en) * 1992-06-05 1995-10-17 Telor Ophthalmic Pharmaceuticals, Inc. Methods and products for treating presbyopia
US5422166A (en) * 1993-02-12 1995-06-06 Wangner Systems Corporation Abrasion resisting edge for a forming fabric
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US5596011A (en) 1995-04-06 1997-01-21 Repine; Karen M. Method for the treatment of macular degeneration
WO1997040834A1 (fr) 1996-04-26 1997-11-06 Fujisawa Pharmaceutical Co., Ltd. Agents ameliorant la circulation peripherique pour tissus ophthalmiques contenant des dihydropyridines
US6066675A (en) * 1996-09-13 2000-05-23 The Regents Of The University Of California Method for treatment of retinal diseases
CA2270119A1 (en) 1996-10-28 1998-05-07 Senju Pharmaceutical Co., Ltd. Drugs for ameliorating ocular circulatory disorders
CA2323749A1 (en) 1998-03-06 1999-09-10 William E. Sponsel Composition and method for treating macular disorders
US6028099A (en) 1998-03-13 2000-02-22 John Hopkins University, School Of Medicine Use of an inhibitor of the protein tyrosine kinase pathway in the treatment of choroidal neovascularization
AU4713499A (en) * 1998-06-27 2000-01-17 Photogenesis, Inc. Ophthalmic uses of ppargamma agonists and ppargamma antagonists
CA2363503C (en) * 1999-03-05 2009-03-10 University Of Iowa Research Foundation Diagnostics and therapeutics for drusen associated ocular disorders
IL137429A0 (en) 1999-07-28 2001-07-24 Pfizer Prod Inc Methods and compsitions for treating diseases and conditions of the eye
EP1246605A2 (en) * 1999-08-10 2002-10-09 The Board Of Regents, The University Of Texas System Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow
JP4372905B2 (ja) * 1999-09-02 2009-11-25 興和株式会社 網膜神経細胞保護剤
US20030007971A1 (en) * 2000-01-31 2003-01-09 Hideaki Hara Remedies for ophthalmic diseases
WO2001087328A2 (en) * 2000-05-12 2001-11-22 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
US6692759B1 (en) * 2000-06-28 2004-02-17 The Regents Of The University Of California Methods for preparing and using implantable substance delivery devices
US20030171375A1 (en) * 2002-02-13 2003-09-11 Brazzell Romulus Kimbro Method for treating ocular neovascular diseases
US7985422B2 (en) 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
US7491312B2 (en) * 2002-10-30 2009-02-17 Edison Pharmaceuticals, Inc. Identifying therapeutic compounds based on their physical-chemical properties
JP2004250347A (ja) * 2003-02-18 2004-09-09 Ajinomoto Co Inc 網膜虚血に基づく疾患の治療および／又は予防剤
US20040214215A1 (en) 2003-03-07 2004-10-28 Yu Ruey J. Bioavailability and improved delivery of alkaline pharmaceutical drugs
US20050059744A1 (en) * 2003-09-12 2005-03-17 Allergan, Inc. Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
AU2005304770A1 (en) * 2004-11-08 2006-05-18 Nicox S.A. Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders

Also Published As

Publication number Publication date
EP2508182B1 (en) 2016-07-06
AU2006247892B2 (en) 2010-04-22
US20120071485A1 (en) 2012-03-22
JP5335419B2 (ja) 2013-11-06
US20130059841A1 (en) 2013-03-07
EP2508183B1 (en) 2014-07-09
ES2598277T3 (es) 2017-01-26
EP2508183A1 (en) 2012-10-10
CA2608163C (en) 2011-10-25
JP5643263B2 (ja) 2014-12-17
EP1885371A4 (en) 2010-04-07
JP2008540528A (ja) 2008-11-20
US8318741B2 (en) 2012-11-27
JP2012229257A (ja) 2012-11-22
US8088773B2 (en) 2012-01-03
AU2006247892A1 (en) 2006-11-23
PL2508182T3 (pl) 2017-05-31
CA2608163A1 (en) 2006-11-23
US20060276458A1 (en) 2006-12-07
EP1885371A1 (en) 2008-02-13
WO2006124324A1 (en) 2006-11-23
DE202006020318U1 (de) 2008-07-31
EP2508182A1 (en) 2012-10-10
US20120115959A1 (en) 2012-05-10
US20120196868A1 (en) 2012-08-02

Similar Documents

Publication Publication Date Title
HK1177419A1 (en) Interleukin-1 blocker for use in the treatment of age-related macular degeneration -1
IL186973A0 (en) Compositions and methods for treatment for neoplasms
EP1893216A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
AU2006279280A8 (en) Methods and compositions for treating neurological disease
EP1737482A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES
EP1922309A4 (en) N-PHENYL-2-PYRIMDINAMINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
ZA200805146B (en) Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
PT2374472T (pt) Composições e métodos para o tratamento de afeções oftalmológicas
ZA200806111B (en) Compositions and methods for preserving brain function
EP1901733A4 (en) USE OF HUPERZINE FOR DISEASES
GB0506759D0 (en) Combination treatment methods
IL186963A0 (en) Methods and compositions for treating pain
EP1863899A4 (en) COMPOSITIONS FOR TREATING SKIN
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
AU2006251169A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251167A8 (en) Tetrahydropyridothiophenes for use in the treatment of cancer
IL188390A0 (en) Imidazolyl-pyrimidine compounds for use in the treatment of proliferative disorders
PL1959957T3 (pl) Pochodne pirymidyloaminobenzamidu do leczenia neurowłókniakowatości
EP1898921A4 (en) COMPOSITIONS AND METHODS FOR TREATING SLEEP DISORDERS
GB0525540D0 (en) New treatment
GB0625844D0 (en) The treatment of macular degeneration
GB2416693B (en) Composition for reducing blood lipids
GB0511769D0 (en) Treatment
GB0620695D0 (en) Composition and methods for the treatment of nurdegenerative disease
GB0523291D0 (en) Treatment table

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190507